KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Common Equity (2016 - 2025)

Maxlinear (MXL) has disclosed Common Equity for 16 consecutive years, with $451.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity fell 12.47% to $451.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $451.9 million, a 12.47% decrease, with the full-year FY2025 number at $451.9 million, down 12.47% from a year prior.
  • Common Equity was $451.9 million for Q4 2025 at Maxlinear, down from $464.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $746.0 million in Q2 2023 to a low of $420.8 million in Q1 2021.
  • A 5-year average of $564.3 million and a median of $542.4 million in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 39.08% in 2023, then decreased 24.77% in 2024.
  • Maxlinear's Common Equity stood at $489.2 million in 2021, then surged by 38.26% to $676.4 million in 2022, then increased by 1.46% to $686.3 million in 2023, then decreased by 24.77% to $516.3 million in 2024, then dropped by 12.47% to $451.9 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's Common Equity are $451.9 million (Q4 2025), $464.7 million (Q3 2025), and $488.3 million (Q2 2025).